India Glass Pharmaceutical Packaging Materials Market, By Product (Ampoules, Bottles, Vials, Syringes, Cartridges, Other), By Material (Type I Glass, Type II Glass, Type III Glass), By Application (Oral Medications, Injectable Medications, Nasal Medications, Other), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Glass Pharmaceutical Packaging Materials Market was valued at USD 983.00 Million in 2024 and is expected to reach USD 1573.02 Million by 2030 with a CAGR of 8.11% during the forecast period.

The Indian glass pharmaceutical packaging market is witnessing robust growth, fueled by the rapid expansion of the pharmaceutical sector and a heightened emphasis on secure, sustainable packaging solutions. This growth trajectory is underpinned by the rising preference for glass due to its chemical inertness, which ensures the integrity of sensitive pharmaceutical products, and its environmental benefits as a fully recyclable material.

The market is expected to sustain its upward momentum, driven by increasing regulatory emphasis on safety standards and a global push towards eco-friendly practices. The integration of advanced glass manufacturing technologies and the scaling up of production capacities by key industry players further bolster this outlook.  The Indian glass pharmaceutical packaging industry is set for long-term growth, presenting considerable opportunities for stakeholders who proactively align their strategies with the evolving demands for innovation, compliance, and sustainability.

Key Market Drivers

Booming Pharmaceutical Industry  

India’s rapidly expanding pharmaceutical industry is a major growth driver for the glass pharmaceutical packaging materials market because the country is the world’s third largest pharmaceutical producer by volume and fourteenth by value, while also supplying about 20 percent of global generic drug exports and serving a broad international customer base through regulated and semi regulated markets.

This strong manufacturing and export footprint is increasing the need for dependable primary packaging such as glass vials, ampoules, cartridges, and syringes, especially as India’s pharmaceutical exports rose to about 27.85 billion dollars in FY 2023 to 2024 and domestic medicine consumption continues to deepen with wider healthcare access.

Glass remains especially important for injectables, biologics, and other sensitive formulations because drug makers require packaging that offers chemical inertness, barrier protection, and compliance with increasingly stringent quality expectations in both domestic and overseas supply chains. The demand is clearly visible at the company level, as PGP Glass said its pharmaceuticals division revenue rose 10.6 percent year on year from Rs 7,767 million in FY 2023 to Rs 8,588 million in FY 2024, while also stating that it holds a 35 percent share in the Indian pharmaceutical glass packaging market.

For instance, Schott Kaisha said its automated plant investment in Gujarat lifted its India production capacity by 50 percent to around 2 billion ampoules and vials annually, highlighting how leading packaging companies are expanding capacity to keep pace with India’s rising pharmaceutical output and higher quality packaging requirements.

Technological Advancements in Glass Manufacturing

Technological advancements in glass manufacturing are significantly transforming India’s glass pharmaceutical packaging market by improving performance, efficiency, and sustainability. Innovations such as lightweighting reduce material usage and transportation costs while maintaining strength, making glass more cost-effective for large-scale pharmaceutical production. Chemical tempering enhances durability, minimizing breakage during handling and transit, which is critical for vials and ampoules used in injectables.

The development of high-purity Type I borosilicate glass has further strengthened demand, as it offers superior resistance to thermal and chemical stress, ensuring drug stability and regulatory compliance. Advanced inner coatings prevent contamination and extend shelf life, particularly for sensitive biologics. Additionally, tamper-evident designs and digital tracking technologies like QR codes and RFID improve product safety and supply chain transparency.

Automation and precision manufacturing ensure consistent quality and scalability, while AI-driven inspection systems enhance defect detection. Sustainable innovations, including recycled glass usage and energy-efficient production methods, align with industry goals. Together, these advancements are driving the adoption of high-quality, reliable glass packaging solutions across India’s pharmaceutical sector.

Sustainability and Environmental Considerations

Sustainability and environmental considerations are becoming a major growth engine for India’s glass pharmaceutical packaging market because glass is a permanent, 100% and infinitely recyclable material, allowing pharmaceutical companies to pursue circular packaging goals without compromising product safety, purity, or barrier performance.

This advantage is gaining greater importance as India tightens its stance on waste and sustainability, with the government enforcing a ban on identified single-use plastic items from July 1, 2022, encouraging manufacturers across packaging value chains to adopt materials that better meet long-term environmental compliance and global customer expectations. At the same time, the market is benefiting from technology led improvements such as higher cullet use, renewable energy integration, and lightweighting, which help reduce emissions and resource intensity while preserving the premium and chemically inert qualities required in pharmaceutical packaging.

For instance, PGP Glass reported 33 percent cullet usage including internal cullet, 61.7 percent renewable electricity capacity, and 68.4 percent water recycling in FY24, while AGI Greenpac said its shift toward renewable sources reduced annual carbon emissions by about 22,970 tonnes and that it reuses 100 percent of production waste, showing how leading companies in India are translating sustainability into measurable operating performance and stronger packaging credibility for pharmaceutical customers.

Download Free Sample Report

Key Market Challenges

High Manufacturing and Operational Costs

Cost pressures remain a major restraint on the India glass pharmaceutical packaging materials market because glass production depends on energy intensive melting and forming processes, and CARE Ratings explicitly identifies power and fuel as a significant cost item for AGI Greenpac, adding that the company has repeatedly invested in multi fuel capability to control these expenses when natural gas prices rise.

The capital burden is equally heavy, since large scale operations require continuous furnace investments, automation, and quality systems, which is evident in AGI Greenpac’s installed glass capacity of 2,000 tonnes per day and in PGP Glass’s FY24 refurbishment of a 105 tonnes per day furnace alongside a 65 tonnes per day brownfield expansion in India. These economics create a clear scale advantage for larger manufacturers, while smaller and mid sized players face higher barriers to entry and modernization. Glass also remains less cost efficient than plastic in logistics because it is heavier and more fragile, which raises transportation, storage, and handling costs and increases the risk of breakage across pharmaceutical distribution networks.

For instance, AGI Greenpac stated that commissioning its new specialty glass manufacturing plant increased depreciation costs, while CARE Ratings also noted that the heating involved in producing each glass bottle and the transportation of glass bottles add to cost pressures, showing why adoption can be slower in India’s price sensitive pharmaceutical packaging environment.

Competition from Alternative Packaging Materials

Plastics remain a popular choice for pharmaceutical packaging due to their lightweight nature, lower production costs, and durability. Advanced plastic materials, such as polyethylene terephthalate (PET), mimic some of the functional benefits of glass, such as transparency and chemical resistance. The widespread availability and cost-efficiency of plastics create strong competition for glass in the pharmaceutical sector.

Innovations in biodegradable and compostable plastics are providing pharmaceutical companies with eco-friendly alternatives to traditional glass. These materials often have better shatter resistance and lower weight compared to glass. The adoption of these new materials diverts demand away from glass, particularly in applications where weight and breakage resistance are critical. While glass is ideal for certain pharmaceutical products, such as injectables and biologics, its use is limited for other formulations like solid-dose medications, where plastics and aluminum dominate. This restricts the overall market share of glass within the broader pharmaceutical packaging segment.

Key Market Trends

Rising Demand for Advanced Drug Delivery Systems

The growing prevalence of chronic diseases and the increasing adoption of biologics and biosimilars are fueling the demand for injectable drug delivery systems. Glass containers, such as vials, ampoules, and prefilled syringes, are the preferred packaging materials for these therapies due to their chemical inertness and ability to maintain drug stability. As the pharmaceutical industry focuses more on precision medicine and targeted therapies, the need for high-quality glass packaging is expected to grow exponentially.

The development of advanced glass syringes and cartridges, featuring improved break resistance and superior compatibility with a wide range of drugs, is gaining traction. These innovations address safety and efficacy requirements for next-generation drugs. Glass packaging manufacturers are investing in research and development to cater to the increasing demand for complex drug formulations. The continued emphasis on immunization programs, bolstered by learnings from the COVID-19 pandemic, has increased the production of vaccines. Glass packaging, particularly borosilicate glass vials, remains indispensable for maintaining the sterility and efficacy of vaccines. This trend is expected to sustain the demand for glass packaging solutions in the pharmaceutical sector.

Emphasis on Sustainability and Eco-Friendly Packaging

With rising environmental awareness, pharmaceutical companies are integrating sustainable practices into their operations. Glass, being 100% recyclable and environmentally friendly, is emerging as the material of choice for companies looking to align with green initiatives. The push towards a circular economy strengthens the market position of glass packaging, as it helps companies achieve sustainability goals and meet regulatory requirements.

Consumers are increasingly favoring brands that adopt sustainable packaging solutions. Glass packaging, often associated with premium quality and environmental responsibility, appeals to eco-conscious consumers. Pharmaceutical companies leveraging glass packaging as part of their sustainability strategies are likely to gain a competitive edge in the market. Innovations in energy-efficient glass production techniques, such as the use of renewable energy and advancements in recycling technology, are reducing the carbon footprint of glass packaging. These advancements support the growth of the glass packaging market by making it more sustainable and cost-effective.

Segmental Insights

Product Insights

Based on the category of Product, the Vials segment emerged as the dominant in the India Glass Pharmaceutical Packaging Materials market in 2024. Vials, particularly glass vials, dominate the India Glass Pharmaceutical Packaging Materials Market due to their widespread use in packaging injectables, vaccines, and biologics. Glass is the preferred material for vials due to its chemical inertness, ability to preserve the integrity of sensitive drugs, and the sterility it provides.

The increasing production of biologics, vaccines, and other injectable drugs has significantly driven the demand for glass vials. Vials are essential for maintaining the stability and sterility of these high-value and temperature-sensitive products. As biologics and vaccines become a more significant part of the pharmaceutical industry, the demand for vials continues to rise. Vials are particularly suited for packaging these products due to their capacity for precise dosage and compatibility with sterilization processes. The surge in vaccine production and the shift towards biologics will continue to drive vial demand, reinforcing its position as the leading segment in the market. These factors are expected to drive the growth of this segment.

Download Free Sample Report

Regional Insights

West India emerged as the dominant in India Glass Pharmaceutical Packaging Materials in 2024, holding the largest market share in terms of value. West India, particularly states like Maharashtra, Gujarat, and Goa, is the largest and most prominent region in the Indian Glass Pharmaceutical Packaging Materials Market. Maharashtra, and more specifically the city of Mumbai, is home to India’s pharmaceutical industry’s financial capital. Gujarat is another key player, known for its robust pharmaceutical manufacturing infrastructure and the presence of major pharmaceutical giants. These states are integral to the national and international supply chain of pharmaceutical products, with numerous large-scale pharmaceutical manufacturers and exporters based here. The high concentration of pharmaceutical companies directly drives demand for pharmaceutical packaging, particularly glass containers for injectables, vials, and ampoules, which are integral to the production of biologics, vaccines, and injectables.

West India, especially Maharashtra and Gujarat, is a major exporter of pharmaceutical products, including those packaged in glass containers. The high demand for quality packaging, particularly glass packaging, is driven by international regulatory requirements and market standards, which demand durable, reliable, and safe packaging solutions. West India’s export activity significantly boosts the market for glass pharmaceutical packaging materials, as international markets favor glass packaging for its chemical inertness and safety. West India is well-equipped with advanced manufacturing infrastructure, industrial zones, and transportation networks, making it an ideal location for the glass pharmaceutical packaging industry. The region also has access to major ports like Mumbai Port and Jawaharlal Nehru Port, facilitating the export of pharmaceutical products. The logistical advantages and strong infrastructure in West India support the seamless production and distribution of glass pharmaceutical packaging, further bolstering its dominant market position.

Recent Developments

• In March 2025, AGI Greenpac announced plans to invest about Rs 700 crore in a new container-glass plant in Madhya Pradesh with a planned daily production capacity of 500 tonnes. Pharmabiz reported that the plant will manufacture commercial glass for sectors including pharmaceuticals, indicating a fresh capacity buildout relevant to vials, bottles, and other pharma glass packaging demand in India. While this was an investment-led development rather than a finished product launch, it still stands out as an important market move because it expands domestic glass-manufacturing infrastructure for pharmaceutical packaging applications.
• In May 2025, Nipro India unveiled a glass cartridge expansion at its Pune plant, with production scheduled to begin in July 2025 for dental and pen applications. The company said the expansion would add local output of high-quality glass cartridges and help meet rising demand across Asia, which is important because cartridges are a core primary packaging format for injectable drug delivery systems. For India’s glass pharmaceutical packaging materials market, this counted as a meaningful launch because it added domestic manufacturing capability in a specialized glass format tied to precision-dose therapies and device-based delivery.
• In September 2025, Corning and SGD Pharma inaugurated a new glass tubing facility in Telangana to expand pharmaceutical manufacturing and strengthen the local primary glass packaging supply chain. The facility combines Corning’s Velocity Vial technology with SGD Pharma’s vial-converting expertise, and the companies said the site is intended to help address both capacity constraints and quality requirements in pharmaceutical glass packaging. This development is especially relevant for India because it represents a concrete collaboration between a global glass-technology company and a specialist pharma-packaging manufacturer to localize higher-performance vial inputs.
• In August 2025, SCHOTT announced the launch of locally manufactured syringe and cartridge glass tubing at its Jambusar, Gujarat facility, becoming the first company in India to produce this category domestically. The company said the move expands its Indian portfolio beyond vial and ampoule tubing and is meant to support rising demand for injectable drug-delivery formats such as pre-filled syringes and cartridges, including those used for GLP-1 therapies. This was a notable breakthrough for India’s primary pharma glass packaging industry because it deepened local self-reliance in high-precision Type I glass components that had previously depended more heavily on imports.

Key Market Players

• Corning Incorporated
• Nipro Medical India Pvt. Ltd
• SGD Pharma India Ltd
• West Pharmaceutical Services, Inc
• Gerresheimer AG
• SCHOTT Poonawalla
• Piramal Enterprises Ltd.
• ŞİŞECAM FLAT GLASS INDIA LTD
• DWK Life Sciences

Report Scope:

In this report, the India Glass Pharmaceutical Packaging Materials Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Glass Pharmaceutical Packaging Materials Market, By Product:

o   Ampoules

o   Bottles

o   Vials

o   Syringes

o   Cartridges

o   Other

• India Glass Pharmaceutical Packaging Materials Market, By Material:

o   Type I Glass

o   Type II Glass

o   Type III Glass

• India Glass Pharmaceutical Packaging Materials Market, By Application:

o   Oral Medications

o   Injectable Medications

o   Nasal Medications

o   Other

• India Glass Pharmaceutical Packaging Materials Market, By Region:

o   North India

o   South India

o   East India

o   West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Glass Pharmaceutical Packaging Materials Market.

Available Customizations:

 India Glass Pharmaceutical Packaging Materials market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).